↓ Skip to main content

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
14 tweeters

Citations

dimensions_citation
167 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
Published in
Journal of Experimental & Clinical Cancer Research, April 2019
DOI 10.1186/s13046-019-1156-5
Pubmed ID
Authors

Qi Zhang, Sihong Lu, Tianfu Li, Liang Yu, Yunjian Zhang, Huijuan Zeng, Xueke Qian, Jiong Bi, Ying Lin

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 122 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 12%
Researcher 14 11%
Unspecified 10 8%
Student > Ph. D. Student 9 7%
Student > Master 9 7%
Other 16 13%
Unknown 49 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 17%
Medicine and Dentistry 18 15%
Unspecified 10 8%
Immunology and Microbiology 6 5%
Engineering 6 5%
Other 10 8%
Unknown 51 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2022.
All research outputs
#3,209,067
of 24,395,432 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#155
of 2,219 outputs
Outputs of similar age
#67,564
of 354,943 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#6
of 70 outputs
Altmetric has tracked 24,395,432 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,219 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,943 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.